Skip to main content
logo
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.350
-0.040 (-0.91%)
At close: Aug 4, 2026, 4:00 PM EDT
4.520
+0.170 (3.91%)
Pre-market: Aug 5, 2026, 7:19 AM EDT

Lifecore Biomedical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 May '25 May '24 May '23 May '22 May '21
Revenue
124.22128.87128.26103.27111.27100.87
Revenue Growth
-3.61%0.47%24.20%-7.19%10.31%-36.98%
Gross Profit
37.0940.341.8527.9939.0738.94
Operating Income
-4.82-17.25-8.84-21.8-11.79-8.82
Net Income
-40.02-44.3612.01-99.56-117.41-23.44
Earnings Per Share
-1.07-1.270.33-3.32-3.97-1.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Dec '25 May '25 May '24 May '23 May '22
Cash & Investments
17.2417.478.278.4619.090.99
Total Debt
154.1141.28127123.73112.62150.2
Net Cash (Debt)
-136.86-123.81-118.73-115.26-93.53-149.21
Net Cash Growth
------
Net Cash Per Share
-3.65-3.30-3.41-3.14-3.12-5.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 May '25 May '24 May '23 May '22 May '21
Operating Cash Flow
15.08-0.210.26-17.44-22.5916.47
Capital Expenditures
-8.73-13.42-18.4-21.48-29.94-25.22
Free Cash Flow
6.35-13.62-18.14-38.92-52.53-8.75
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 May '25 May '24 May '23 May '22 May '21
Gross Margin
29.86%31.27%32.63%27.10%35.11%38.60%
Operating Margin
-3.88%-13.38%-6.90%-21.11%-10.60%-8.75%
Pretax Margin
-28.85%-30.01%7.42%-61.90%-18.59%-29.53%
Profit Margin
-28.52%-30.04%7.28%-62.20%-13.91%-23.23%
FCF Margin
0.00%-10.57%-14.14%-37.69%-47.21%-8.68%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 May '25 May '24 May '23 May '22
PE Ratio
---17.03--
Forward PE
-8.178.1725.55167.00250.59
PS Ratio
1.26-1.931.342.332.62